Physician profile
Dimitri Krainc
NPI 1588654032
$15,644.14
in general payments reported to CMS, 2019-2025
5 companies · $4,525 in 2025
The $4,525 reported for 2025 was more than what 84% of Neurology (Psychiatry & Neurology) providers received nationally (typical 2025 total: $454).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $1,500 · 2021: $9,620 · 2025: $4,525.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $4,403 · Travel and Lodging: $80.00 · Food and Beverage: $42.07.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $4,402.50 |
| Travel and Lodging | $80.00 |
| Food and Beverage | $42.07 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Eli Lilly and Company | $9,619.57 | 2021 | |
| F. Hoffmann-La Roche Ag | $3,304.57 | 2025 | |
| Sumitomo Pharma Co., LTD. | $1,500.00 | 2020 | |
| Genentech, INC. | $1,220.00 | 2025 |
1 company reported research payments only; those appear in the research section below.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Dimitri Krainc listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.